QQQ   332.28 (-0.23%)
AAPL   173.03 (-0.09%)
MSFT   292.71 (-0.26%)
META   179.47 (-0.79%)
GOOGL   121.70 (-0.31%)
AMZN   144.78 (+1.12%)
TSLA   919.69 (-0.89%)
NVDA   188.79 (-0.80%)
NIO   20.91 (-1.83%)
BABA   92.65 (-1.65%)
AMD   100.20 (-0.80%)
MU   63.86 (-1.30%)
T   18.57 (+0.98%)
CGC   3.78 (-1.05%)
F   16.43 (+0.67%)
GE   81.07 (+1.58%)
DIS   124.96 (+0.56%)
AMC   24.81 (+2.48%)
PYPL   102.08 (+0.56%)
PFE   49.86 (+0.22%)
NFLX   245.69 (-1.37%)
QQQ   332.28 (-0.23%)
AAPL   173.03 (-0.09%)
MSFT   292.71 (-0.26%)
META   179.47 (-0.79%)
GOOGL   121.70 (-0.31%)
AMZN   144.78 (+1.12%)
TSLA   919.69 (-0.89%)
NVDA   188.79 (-0.80%)
NIO   20.91 (-1.83%)
BABA   92.65 (-1.65%)
AMD   100.20 (-0.80%)
MU   63.86 (-1.30%)
T   18.57 (+0.98%)
CGC   3.78 (-1.05%)
F   16.43 (+0.67%)
GE   81.07 (+1.58%)
DIS   124.96 (+0.56%)
AMC   24.81 (+2.48%)
PYPL   102.08 (+0.56%)
PFE   49.86 (+0.22%)
NFLX   245.69 (-1.37%)
QQQ   332.28 (-0.23%)
AAPL   173.03 (-0.09%)
MSFT   292.71 (-0.26%)
META   179.47 (-0.79%)
GOOGL   121.70 (-0.31%)
AMZN   144.78 (+1.12%)
TSLA   919.69 (-0.89%)
NVDA   188.79 (-0.80%)
NIO   20.91 (-1.83%)
BABA   92.65 (-1.65%)
AMD   100.20 (-0.80%)
MU   63.86 (-1.30%)
T   18.57 (+0.98%)
CGC   3.78 (-1.05%)
F   16.43 (+0.67%)
GE   81.07 (+1.58%)
DIS   124.96 (+0.56%)
AMC   24.81 (+2.48%)
PYPL   102.08 (+0.56%)
PFE   49.86 (+0.22%)
NFLX   245.69 (-1.37%)
QQQ   332.28 (-0.23%)
AAPL   173.03 (-0.09%)
MSFT   292.71 (-0.26%)
META   179.47 (-0.79%)
GOOGL   121.70 (-0.31%)
AMZN   144.78 (+1.12%)
TSLA   919.69 (-0.89%)
NVDA   188.79 (-0.80%)
NIO   20.91 (-1.83%)
BABA   92.65 (-1.65%)
AMD   100.20 (-0.80%)
MU   63.86 (-1.30%)
T   18.57 (+0.98%)
CGC   3.78 (-1.05%)
F   16.43 (+0.67%)
GE   81.07 (+1.58%)
DIS   124.96 (+0.56%)
AMC   24.81 (+2.48%)
PYPL   102.08 (+0.56%)
PFE   49.86 (+0.22%)
NFLX   245.69 (-1.37%)
NASDAQ:IRTC

iRhythm Technologies - IRTC Stock Forecast, Price & News

$154.30
+1.66 (+1.09%)
(As of 08/16/2022 12:00 AM ET)
Add
Compare
Today's Range
$147.27
$154.67
50-Day Range
$107.95
$157.98
52-Week Range
$41.66
$169.54
Volume
345,734 shs
Average Volume
396,505 shs
Market Capitalization
$4.63 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$148.45

iRhythm Technologies MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.70 Rating Score
Upside/​Downside
3.8% Downside
$148.45 Price Target
Short Interest
Bearish
6.64% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
1.01mentions of iRhythm Technologies in the last 14 days
Based on 6 Articles This Week
Insider Trading
Selling Shares
$1.50 M Sold Last Quarter
Proj. Earnings Growth
Growing
From ($3.06) to ($2.19) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.35 out of 5 stars

Medical Sector

1084th out of 1,124 stocks

Surgical & Medical Instruments Industry

107th out of 113 stocks

IRTC stock logo

About iRhythm Technologies (NASDAQ:IRTC) Stock

iRhythm Technologies, Inc., a digital healthcare company, provides ambulatory electrocardiogram (ECG) monitoring products for patients at risk for arrhythmias in the United States. It offers Zio service, an ambulatory cardiac monitoring solution that combines a wire-free, patch-based, and wearable biosensor with a cloud-based data analytic platform to help physicians to monitor patients and diagnose arrhythmias. The company's Zio XT and AT monitors, a single-use, wire-free, and wearable patch-based biosensors, records patient's heartbeats and ECG data. It has a development collaboration agreement with Verily Life Sciences LLC to develop various next-generation atrial fibrillation screening, detection, or monitoring products. The company was incorporated in 2006 and is headquartered in San Francisco, California.

Wall Street Analyst Weigh In

IRTC has been the subject of several recent analyst reports. Citigroup increased their price objective on shares of iRhythm Technologies to $157.00 in a research report on Tuesday, August 9th. Truist Financial decreased their price objective on shares of iRhythm Technologies from $200.00 to $165.00 and set a "buy" rating for the company in a research report on Thursday, June 16th. BTIG Research increased their price objective on shares of iRhythm Technologies from $155.00 to $178.00 and gave the stock a "buy" rating in a research report on Friday, August 5th. Finally, JPMorgan Chase & Co. reiterated an "overweight" rating and set a $135.00 price objective (down from $183.00) on shares of iRhythm Technologies in a research report on Wednesday, June 22nd. Two equities research analysts have rated the stock with a sell rating, one has assigned a hold rating and nine have given a buy rating to the company. According to MarketBeat.com, iRhythm Technologies presently has an average rating of "Moderate Buy" and an average price target of $155.75.

iRhythm Technologies Stock Up 0.8 %

iRhythm Technologies stock opened at $152.64 on Tuesday. iRhythm Technologies has a 1-year low of $41.66 and a 1-year high of $169.54. The firm has a market capitalization of $4.58 billion, a price-to-earnings ratio of -34.53 and a beta of 1.50. The firm's fifty day moving average price is $133.76 and its two-hundred day moving average price is $133.60. The company has a current ratio of 4.04, a quick ratio of 3.84 and a debt-to-equity ratio of 0.14.

iRhythm Technologies (NASDAQ:IRTC - Get Rating) last released its quarterly earnings data on Thursday, August 4th. The company reported ($0.80) earnings per share for the quarter, beating analysts' consensus estimates of ($0.94) by $0.14. iRhythm Technologies had a negative net margin of 36.15% and a negative return on equity of 38.95%. The firm had revenue of $102.10 million for the quarter, compared to analyst estimates of $100.51 million. During the same period last year, the firm earned ($0.59) earnings per share. The business's quarterly revenue was up 25.6% compared to the same quarter last year. On average, equities research analysts predict that iRhythm Technologies will post -3.06 earnings per share for the current fiscal year.

Insider Buying and Selling at iRhythm Technologies

In other iRhythm Technologies news, EVP Daniel G. Wilson sold 1,428 shares of the firm's stock in a transaction on Tuesday, July 5th. The shares were sold at an average price of $108.93, for a total value of $155,552.04. Following the transaction, the executive vice president now directly owns 37,562 shares of the company's stock, valued at $4,091,628.66. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. In related news, EVP Daniel G. Wilson sold 1,428 shares of the firm's stock in a transaction dated Tuesday, July 5th. The shares were sold at an average price of $108.93, for a total transaction of $155,552.04. Following the transaction, the executive vice president now directly owns 37,562 shares of the company's stock, valued at $4,091,628.66. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CFO Douglas Devine sold 10,109 shares of the firm's stock in a transaction dated Thursday, July 7th. The shares were sold at an average price of $114.22, for a total transaction of $1,154,649.98. Following the transaction, the chief financial officer now directly owns 29,702 shares in the company, valued at $3,392,562.44. The disclosure for this sale can be found here. Over the last three months, insiders have sold 13,276 shares of company stock valued at $1,501,009. Corporate insiders own 1.64% of the company's stock.

Receive IRTC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for iRhythm Technologies and its competitors with MarketBeat's FREE daily newsletter.

IRTC Stock News Headlines

Expert Ratings for iRhythm Technologies
See More Headlines
Receive IRTC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for iRhythm Technologies and its competitors with MarketBeat's FREE daily newsletter.

IRTC Company Calendar

Last Earnings
8/04/2022
Today
8/16/2022
Next Earnings (Estimated)
11/03/2022
Fiscal Year End
12/31/2022

Industry, Sector and Symbol

Industry
Surgical & medical instruments
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:IRTC
Fax
N/A
Employees
1,700
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$148.45
High Stock Price Forecast
$178.00
Low Stock Price Forecast
$105.00
Forecasted Upside/Downside
-3.8%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.70
Research Coverage
10 Analysts

Profitability

Net Income
$-101,360,000.00
Pretax Margin
-36.08%

Debt

Sales & Book Value

Annual Sales
$322.83 million
Book Value
$9.50 per share

Miscellaneous

Free Float
29,535,000
Market Cap
$4.63 billion
Optionable
Optionable
Beta
1.50














IRTC Stock - Frequently Asked Questions

Should I buy or sell iRhythm Technologies stock right now?

10 Wall Street analysts have issued "buy," "hold," and "sell" ratings for iRhythm Technologies in the last year. There are currently 1 sell rating, 1 hold rating and 8 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" IRTC shares.
View IRTC analyst ratings
or view top-rated stocks.

What is iRhythm Technologies' stock price forecast for 2022?

10 Wall Street research analysts have issued 1 year target prices for iRhythm Technologies' shares. Their IRTC share price forecasts range from $105.00 to $178.00. On average, they expect the company's stock price to reach $148.45 in the next twelve months. This suggests that the stock has a possible downside of 3.8%.
View analysts price targets for IRTC
or view top-rated stocks among Wall Street analysts.

How have IRTC shares performed in 2022?

iRhythm Technologies' stock was trading at $117.69 at the start of the year. Since then, IRTC shares have increased by 31.1% and is now trading at $154.30.
View the best growth stocks for 2022 here
.

When is iRhythm Technologies' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, November 3rd 2022.
View our IRTC earnings forecast
.

How were iRhythm Technologies' earnings last quarter?

iRhythm Technologies, Inc. (NASDAQ:IRTC) posted its earnings results on Thursday, August, 4th. The company reported ($0.80) earnings per share for the quarter, beating the consensus estimate of ($0.94) by $0.14. The company had revenue of $102.10 million for the quarter, compared to the consensus estimate of $100.51 million. iRhythm Technologies had a negative net margin of 36.15% and a negative trailing twelve-month return on equity of 38.95%. iRhythm Technologies's revenue was up 25.6% on a year-over-year basis. During the same period in the prior year, the firm earned ($0.59) EPS.

What guidance has iRhythm Technologies issued on next quarter's earnings?

iRhythm Technologies issued an update on its FY 2022 earnings guidance on Tuesday, August, 16th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $415.00 million-$420.00 million, compared to the consensus revenue estimate of $417.98 million.

What is Kevin M. King's approval rating as iRhythm Technologies' CEO?

20 employees have rated iRhythm Technologies Chief Executive Officer Kevin M. King on Glassdoor.com. Kevin M. King has an approval rating of 91% among the company's employees. This puts Kevin M. King in the top 30% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of iRhythm Technologies own?

Based on aggregate information from My MarketBeat watchlists, some companies that other iRhythm Technologies investors own include NVIDIA (NVDA), Alibaba Group (BABA), Salesforce (CRM), Block (SQ), Teladoc Health (TDOC), Trade Desk (TTD), Advanced Micro Devices (AMD), Intel (INTC), Broadcom (AVGO) and Boeing (BA).

When did iRhythm Technologies IPO?

(IRTC) raised $76 million in an initial public offering (IPO) on Thursday, October 20th 2016. The company issued 5,400,000 shares at a price of $13.00-$15.00 per share. J.P. Morgan and Morgan Stanley acted as the underwriters for the IPO and Canaccord Genuity and BTIG were co-managers.

What is iRhythm Technologies' stock symbol?

iRhythm Technologies trades on the NASDAQ under the ticker symbol "IRTC."

Who are iRhythm Technologies' major shareholders?

iRhythm Technologies' stock is owned by many different retail and institutional investors. Top institutional shareholders include Sands Capital Management LLC (10.16%), LTS One Management LP (5.12%), JPMorgan Chase & Co. (4.61%), Mackenzie Financial Corp (4.07%), Fiera Capital Corp (2.40%) and State Street Corp (2.34%). Insiders that own company stock include Daniel G Wilson, David A Vort, David A Vort, Douglas Devine, Kevin M King, Mark J Day, Matthew C Garrett, Merz Cathleen Noel Bairey, Ralph Snyderman and Raymond W Scott.
View institutional ownership trends
.

How do I buy shares of iRhythm Technologies?

Shares of IRTC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is iRhythm Technologies' stock price today?

One share of IRTC stock can currently be purchased for approximately $154.30.

How much money does iRhythm Technologies make?

iRhythm Technologies (NASDAQ:IRTC) has a market capitalization of $4.63 billion and generates $322.83 million in revenue each year. The company earns $-101,360,000.00 in net income (profit) each year or ($4.42) on an earnings per share basis.

How many employees does iRhythm Technologies have?

The company employs 1,700 workers across the globe.

How can I contact iRhythm Technologies?

iRhythm Technologies' mailing address is 650 TOWNSEND STREET SUITE 500, San Francisco CA, 94103. The official website for the company is www.irhythmtech.com. The company can be reached via phone at (415) 632-5700 or via email at investors@irhythmtech.com.

This page (NASDAQ:IRTC) was last updated on 8/16/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.